The data from our study show that higher circulating levels of FGF21 and RBM3 on admission and at 72 h, respectively, correlate with good stroke outcomes, which is in line with previous evidence describing FGF21 as an inductor of RBM3, and with the protective effect described for both proteins under mild temperature conditions [9,14]. Here, FGF21 is linked to stroke disorder.